Articles On Bioxyne (ASX:BXN)

Benchmark set to end the day down about 2.0% Geopolitics and overseas rate-raising spree weigh heavily A couple of late bolters bring some small comfort, but really…  Another Friday, and another entirely sub-par experience for anyone watc...

Small caps and benchmark down over 1% All sectors retreat on ill-winds blowing in from the states Tinkler is back   The ASX 200 has started a new week with its worst session since early July. While that can be pinned on a shift in US sent...

The ASX has trundled along like a happy little camper, up nearly 1.0% SZL sizzled then fizzled as the BNPL sector got all turned around So. Many. Quarterlies. Oh. My. God. #pleasemakeitstop   It’s been a happy, smiley Friday for (nearly)...

One big bounce and then steady as she goes for the benchmark today Market mover Douugh can’t explain its sudden popularity, up 29% Wooden spoons all round for Jervois Global after soggy Q2 results It must be the end of the week, because t...

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

Wall Street inspires strong Asian market gains Bubs leads quarterly numbers at home Victory Goldfields becomes Victory REE for Wednesday Let’s start big and go little today. The S&P500 closed 2.6% higher early this morning – best sess...

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

The ASX 200 and XEC small cap indices rise Attention turns to Tuesday’s date with RBA destiny Celsius Resources is hot   The ASX 200 and the Emerging Markets (XEC) indices are both trading higher on Monday up about 1.2%, ahead of tomorrow...

Benchmark lifts on uranium, energy gains Small caps on energy and materials Newcomer Southern Palladium nails debut. Nails. It.   The benchmark is higher and the small cap index is a bit higher, but the real action on a lazy winter Wednes...

Emerging markets index up 0.5% ASX200 1% lower Belararox (ASX:BRX) rocks    The ASX Emerging Companies (XEC) Index was trading 0.6% higher after lunch to the exact degree the ASX200 (XJO) was not, 0.6% weaker. At the close the small cap...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Emerging markets index ends flat ASX200 0.5 higher Chinese economy hit by COVID-lockdowns   Anaemic data out of China has taken the fun out of Monday here in Sydney. April retail sales fell more than 11% year on year, almost twice what wa...

Emerging markets index ends flat ASX200 0.5 higher Chinese economy hit by COVID-lockdowns   Anaemic data out of China has taken the fun out of Monday here in Sydney. April retail sales fell more than 11% year on year, almost twice what wa...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

  Highlights The benchmark ASX Small Ordinaries index plunged more than 2.9% to 3,125.1 by 12:30 PM AEST. IPB, BXN & X2M are three ASX penny stocks that are up over 10% today. Investors should do a proper due diligence before inv...

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

The ASX200 has taken a 0.5% hit on Wednesday, with the tech sector giving back all the previous session’s gains after Wall Street fell and the tech-laden Nasdaq Composite lost 2.3% overnight. The overnight session was dominated by comments...

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

ASX Emerging Companies (XEC) index has closed 1.5% on Tuesday Index now over 10% the better since February 22 Tuesday winners: ResApp (ASX:RAP), RiversGold (ASX:RGL)    The ASX Emerging Companies (XEC) index is 1.5% higher in late trade....

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

The S&P/ASX200 climbed into the close on Tuesday. Most of the 35 or so point gain (0.5%)  comes off the back of some good, steady central banking, delivered – nay, telegraphed – at 2.30pm when the Reserve Bank (RBA) left the cash rate a...

It was a lacklustre session for local stocks in Tuesday trade, as the ASX 200 limped into the close with a fall of 0.77% while the microcap Emerging Companies index traded flat. In an environment of rising bond yields, the broader tone is s...

The Australian sharemarket opened down, extending its loss from the previous session, led by the Consumer Staples sector. The S&P/ASX 200 Index has fallen 53 points, or 0.72 per cent, to 7393.40. Ingham’s is one of the most hit s...

The ASX is down -0.3% today with the information technology sector taking the cake for the biggest dip at ~3%, followed by the healthcare sector at more than 1.5%. The ASX Emerging Companies Index (XEC) has flatlined. For the second day in...

At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform...

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %...

It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont...

ASX recovered some lost ground in arvo trade but still finished 0.54% down, as markets continue to be shaken by the discovery of the omicron variant of COVID-19 and falling oil prices. Resources and tech managed to finish in the green – by...

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

The ASX had a positive finish to the week although it is in negative territory for the week. The ASX 200 closed at 7,443 points which is up 0.83% from yesterday but slightly down from the 7,457 mark it closed at last Friday. Today, the only...

The ASX started the week on a downward note with tech leading the laggards despite one of Australia’s major unicorns joining the bourse and gaining over 30%. SiteMinder (ASX:SDR), a hotel commerce platform, listed on the ASX at $5.06 per sh...

Local stocks lost ground on Thursday, with minor falls at the big end of town and a slightly steeper drop of ~0.8% for the microcap Emerging Markets Index. The ASX opened with a weak lead from Wall Street, after a fortnight of steady gains...

Shares in the once market darling A2 Milk (ASX:A2M) tumbled by 12% today, shortly after releasing an investor update to the market. The update mainly focused on China, where A2M said $NZ250 million worth of daigou sales have been lost due t...

The ASX got off to a solid start today but the rally eased following the release of inflation data. Core inflation rose at the fastest pace since 2015 leading to speculation that the tightening of monetary policy could come sooner than 2024...

The ASX saw a frenzy of M&A deals today and it sent the market higher. Companies completing deals included Ramelius Resources (ASX:RMS) buying Apollo Consolidated (ASX:AOP) and Class (ASX:CL1) being acquired by Hub24 (ASX:HUB) along wit...

It’s been a mixed week for the ASX but it has finished on a high. The ASX 200 closed 0.69% higher than yesterday, closing at 7,362 which marked a 3 week high but is still 3.5% above the all time high reached in mid-August. Travel stocks gai...

The ASX 200 was unable to break free from its recent shackles, edging lower by 0.11% in the Wednesday session. But as a measure of a little more risk-on sentiment creeping back into markets, the microcap Emerging Markets index comfortably o...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Each week, Stockhead recaps ASX stocks that are “running hot” as deduced by the Relative Strength Index (RSI). The RSI is a technical gauge which measures how trading momentum is affecting the price action. A reading of 70 is seen as the le...

The ASX limped into the close on Friday, in a fairly tame finish to a roller-coaster week. Evergrande contagion fears and jitters ahead of the US Fed meeting sparked a sharp selloff on Monday. But a week (or three days) is a long time in ma...

The ASX closed higher today and it was all thanks to the latest moves in the uranium sector. Spot prices have reached ~7 year highs with the latest catalyst being the Sprott Physical Uranium Trust buying up more physical uranium and spot pr...

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

While COVID-19 continues to wreck havoc across NSW, the ASX remained in a state of zen on Wednesday, as local stocks eased to new record highs. The ASX 200 finished around 0.3% higher to close at 7,584, outpaced by the microcap Emerging Com...

While COVID-19 continues to wreck havoc across NSW, the ASX remained in a state of zen on Wednesday, as local stocks eased to new record highs. The ASX 200 finished around 0.3% higher to close at 7,584, outpaced by the microcap Emerging Com...

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...